Identification of biomarkers, pathways, and therapeutic targets for EGFR–TKI resistance in NSCLC

This study aimed to map the hub genes and potential pathways that might be involved in the molecular pathogenesis of EGFR–TKI resistance in NSCLC. We performed bioinformatics analysis to identify differentially expressed genes, their function, gene interactions, and pathway analysis between EGFR–TKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Leilei, Gao, Shanshan, Zhao, Xianya, Wang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2023
Materias:
Resources
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565673/
https://www.ncbi.nlm.nih.gov/pubmed/37816585
http://dx.doi.org/10.26508/lsa.202302110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565673/
https://www.ncbi.nlm.nih.gov/pubmed/37816585
http://dx.doi.org/10.26508/lsa.202302110

Ejemplares similares